Astrazeneca plc
NASDAQ: AZN
$64.18
-$2.09 (-3.2%)
Real Time Data Delayed 15 Min.
AZN Articles
November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2.5 to 1...
Published:
Last Updated:
24/7 Wall St. has put together a preview of Disney, Petrobras and some of the other major companies reporting their quarterly results this week.
Published:
Last Updated:
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
Published:
Last Updated:
A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good sense for long-term growth and income portfolios.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
Published:
Last Updated:
One of the best things for investors to do is look for solid growth potential combined with fair valuations. Sprinkle in dividends and you have a recipe for total return success.
Published:
Last Updated:
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media and Wal-Mart.
Published:
Last Updated:
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Monday morning include Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square and T-Mobile.
Published:
Last Updated:
The broad markets are continuing to hit all-time highs as the market is shifting gears out of the earnings season. Despite all the positive sentiment in the market, quite a few companies still...
Published:
Last Updated:
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Accenture, Cognizant Technology Solutions, Fitbit, Oracle, Seagate Technology and Vodafone.
Published:
Last Updated:
Perhaps the move for a rapid exit by Britain from the European Union (or Brexit) may have been interrupted due to a political murder of M.P. Jo Cox on Thursday. As this was a member of parliament,...
Published:
Last Updated:
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Published:
Last Updated: